| --- | --- | --- | |-------|-------------------------------------------------------------------------------------------------------------------------------------------------|-------| | | | | | | | | | | Early Intervention with | | | | Mission for Vision Nasdaq: BLTE Media and Investor Relations Contact: Jennifer Wu / ir@belitebio.com an Oral Treatment for Macular Degeneration | | Any statements in this presentation about Belite Bio's future expectations, plans and prospects constitute forward-looking state ...